Mechanism of immunomodulatory drugs in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanism of immunomodulatory drugs in multiple myeloma

Published:2012-10 Issue:10 Volume:36 Page:1218-1224
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Sedlarikova Lenka,Kubiczkova Lenka,Sevcikova Sabina,Hajek Roman

Funder

The Czech Science Foundation

The Ministry of Education, Youth and Sports

Ministry of Health of the Czech Republic

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference62 articles.

1. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997;Harris;J Clin Oncol,1999

2. Pathology of myeloma;Anderson;Annu Rev Pathol Mech Dis,2011

3. Multiple myeloma;Hajek;Klinická onkologie,2011

4. Remarks on the pathology of mollities ossium with cases;Solly;Med Chir Trans,1844

5. Case of mollities and fragilitas ossium, accompanied with urine strongly charged with animal matter;Macintyre;Med Chir Trans,1850

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article;Blood and Lymphatic Cancer: Targets and Therapy;2023-09

2. Treatment Strategies for Multiple Myeloma Treatment and the Role of High-Throughput Screening for Precision Cancer Therapy;Cell Biology and Translational Medicine, Volume 20;2023

3. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma;Cancer Immunology, Immunotherapy;2020-07-04

4. SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma;Acta Biochimica et Biophysica Sinica;2019-11-26

5. Challenging the indiscriminate use of temozolomide in pediatric high‐grade gliomas: A review of past, current, and emerging therapies;Pediatric Blood & Cancer;2019-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3